Skip to main content

MetLife Investment Management, LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1529735 Whippany, NJ

Position in AMLX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$717,059
+$117,239 QoQ
Shares Held
51,587
+3.9% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $88,544,808 across 37 Drug Manufacturers - Specialty & Generic names. AMLX ranks #17 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $717,059 51,587
2025-12-31 $599,820 49,654
2025-09-30 $583,405 42,929
2025-06-30 $275,174 42,929
2024-03-31 $39,101 13,768
2023-12-31 $393,200 26,712
2023-09-30 $489,096 26,712
2023-06-30 $576,177 26,712
2023-03-31 $783,730 26,712
2022-12-31 $987,008 26,712
2022-09-30 $547,827 19,461
2022-06-30 $130,679 6,785
2022-03-31 $87,187 6,785